Astrana Health (ASTH) | Stock Overview & Key Data
Astrana Health Performance Comparison
Stock Range
Today's Range
Low: $28.70
High: $30.18
on August 21, 2025
52 Week Range
Low: $21.20
High: $63.20
on August 7, 2025
on October 16, 2024
All-Time High: $133.23 on November 15, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.4B
EPS
0.53
P/E Ratio (TTM)
56.49
Forward P/E
19.57
P/B Ratio
1.92
PEG Ratio
-1.08
Div. Yield
N/A
ROE
5.44%
Beta
0.855
Debt to Equity
83.20
Financial Highlights
Profitability
Gross Margin
11.91%
Operating Margin
3.11%
Profit Margin
1.04%
Returns and Earnings
Return on Assets (TTM)
3.25%
Return on Equity (TTM)
5.44%
EBITDA
$112.4M
Net Income (TTM)
$25.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$50.47
Quarterly Revenue Growth (YoY)
34.70%
Quarterly Earnings Growth (YoY)
-50.80%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Astrana Health ASTH | 1.38B Small-cap | 1.46% | 30.08% | 18.98% | -16.00% | -6.93% | -37.72% | -30.63% | 64.85% |
| HCA Healthcare HCA | 94.23B Large-cap | 2.70% | 10.89% | 5.88% | 27.76% | 35.77% | 3.98% | 97.22% | 197.27% |
| Tenet Healthcare THC | 15.73B Large-cap | 2.92% | 1.57% | 8.94% | 36.88% | 41.66% | 7.82% | 195.31% | 515.72% |
| Acadia Healthcare ACHC | 1.94B Small-cap | 3.68% | -1.02% | -8.89% | -45.98% | -47.46% | -73.19% | -74.08% | -31.41% |
| Select Medical SEM | 1.85B Small-cap | 3.10% | -10.48% | -11.93% | -26.53% | -30.87% | -32.24% | -9.03% | 18.31% |
| Pacs PACS | 1.84B Small-cap | 1.73% | 0.95% | 18.72% | -8.29% | -9.28% | -71.61% | -51.13% | -51.13% |
Ownership & Short Interest
Insider Ownership
22.09%
Institutional Ownership
52.98%
Shares Short
2M
Short Ratio
5.33
Short % of Shares Outstanding
5.56%
Average 10-Day Volume
633K
Average 90-Day Volume
439K
Astrana Health Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Astrana Health would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ASTH's 52-week high and low?
- In the last 52 weeks, Astrana Health reached a high of $63.20 (on October 16, 2024) and a low of $21.20 (on August 7, 2025).
- What is the market cap and P/E ratio for ASTH?
- Curious about Astrana Health's size and valuation? Its market capitalization stands at 1.38B. When it comes to valuation, the P/E ratio (trailing twelve months) is 56.49, and the forward P/E (looking ahead) is 19.57.
- Does ASTH pay dividends? If so, what's the yield?
- As for dividends, Astrana Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Astrana Health's main competitors or similar companies to consider before investing?
When looking at Astrana Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA94.23B Healthcare Medical Care Facilities 3.98% 97.22% Tenet Healthcare
THC15.73B Healthcare Medical Care Facilities 7.82% 195.31% Acadia Healthcare
ACHC1.94B Healthcare Medical Care Facilities -73.19% -74.08% Select Medical
SEM1.85B Healthcare Medical Care Facilities -32.24% -9.03% Pacs
PACS1.84B Healthcare Medical Care Facilities -71.61% -51.13% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Astrana Health Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Astrana Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.44%, the Debt to Equity ratio from the most recent quarter is 83.20, and its Gross Profit Margin stands at 11.91%.
- What is the recent revenue and earnings growth for ASTH?
- Looking at Astrana Health's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 34.70%, and quarterly earnings saw a YoY growth of -50.80%.
- How much of ASTH stock is held by insiders and institutions?
- Wondering who owns Astrana Health stock? Company insiders (like executives and directors) hold about 22.09% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 52.98%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.